Given that BRD4-R179/181/183 methylation is critical for BRD4-ADMA formation, we next construct BRD4-WT and the methylation-deficient mutant of BRD4-R3K in ovarian cancer cells. This evidence concerns the gene BRD4 and ovarian carcinoma.